Loading...
NPI 1639215502 · Waltham, MA · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Boston Eye Surgery & Laser Center Trust is a ambulatory surgical clinic/center provider located in Waltham, Massachusetts. This profile covers 13 Medicare and 3 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Boston Eye Surgery & Laser Center Trust |
| Address | 195 West St Fl 2 |
| City | Waltham |
| State | MA |
| ZIP | 02451 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | January 29, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.4M |
| Medicaid | $67.1K |
Service-line profile: The provider operates as an ambulatory surgical clinic/center focused on ophthalmology, with the case mix dominated by cataract surgery and related anterior-segment procedures — the top Medicare codes are 66984, 66982 and 66991, which correspond to standard and complex intraocular lens insertion and combined cataract-plus-drainage-device procedures. This mix is consistent with a high-throughput eye surgery center offering both routine and some complex cataract care.
Medicare revenue concentration: Medicare is the primary revenue source with total Medicare revenue reported as $2.4M, and the precomputed top 3 Medicare codes by revenue account for 86.8% of that Medicare revenue. That concentration indicates the facility’s financial performance is heavily tied to a small set of cataract-related CPTs.
Medicaid footprint and payer mix: Medicaid revenue is small relative to Medicare, with total Medicaid revenue $67.1K versus Medicare $2.4M, making the practice effectively Medicare-dominant. Medicaid billing is even more concentrated: the precomputed top 3 Medicaid codes account for 100.0% of Medicaid revenue, and 66984 alone generates $66.7K across 226 claims (99.3% of the provider’s Medicaid revenue), signaling minimal diversification in the state program.
Competitive standing on Medicare cataract volume: The provider reports high national standing on key cataract codes — 66984 ranks #1061 of 15965 providers nationally (93th percentile; notably above typical national volume) and 66982 ranks #53 of 4580 providers nationally (99th percentile; notably above typical national volume). These rankings indicate the center is a relatively high-volume national performer for both routine and complex cataract surgery compared with peers.
Complementary services and procedural breadth: Beyond the revenue-driving cataract codes, the provider reports substantial volume for 66821 (YAG capsulotomy) with 415 claims and $88.4K revenue, ranking #279 of 10087 providers nationally (97th percentile; typical, unremarkable volume), and performs a range of glaucoma-related interventions (e.g., 66991 ranks #383 of 1445, 72th percentile; typical, unremarkable volume; 65855 ranks #96 of 2796, 97th percentile; notably above typical national volume). This suggests the center supplements cataract throughput with posterior-capsule laser work and selected glaucoma procedures, supporting a broader ambulatory ophthalmic service line.
Operational risk from code concentration: Heavy reliance on a narrow set of cataract codes creates operational and revenue exposure — with top-3 Medicare codes making up 86.8% of Medicare revenue and top-3 Medicaid codes making up 100.0% of Medicaid revenue, reimbursement changes or local shifts in cataract case volume could materially affect overall revenue. Analysts should treat future policy or market changes to cataract-related reimbursement as high-impact for this provider.
Tenure and market presence: The provider’s NPI was enumerated 2007-01-29 (~19 years ago), indicating long-standing participation in Medicare/Medicaid programs and likely established referral relationships that support sustained cataract surgery volume. This tenure, combined with high national percentiles on core cataract codes, aligns with a mature, specialty ambulatory surgery center profile.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
13 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 1,930 | $880 | $1.7M |
| 66982 | The provider inserts an intraocular lens prosthesis after extracapsular cataract extraction using complex techniques and devices. He may perform this by means of an iris expansion device, providing… | 270 | $880 | $235.8K |
| 66991 | The provider inserts an intraocular lens prosthesis during the same session as extracapsular cataract extraction. The provider also inserts one or more anterior segment aqueous drainage devices in… | 50 | $2,650 | $122K |
| 65820 | The provider incises the limbus to improve drainage of aqueous humor in the eye. This procedure is typically performed on children, usually to treat congenital glaucoma. | 60 | $1,560 | $92.2K |
| 66821 | The provider removes the haziness from the capsule of the eye using a laser for a patient with a secondary membranous cataract. | 420 | $210 | $88.4K |
| V2785 | Processing, preserving and transporting corneal tissue | 10 | $3,470 | $45.1K |
| 66170 | In this procedure, the provider creates a fistula and removes part of the trabecular meshwork to treat glaucoma and relieve intraocular pressure. | 30 | $720 | $20.8K |
| 66250 | The provider repairs or revises a wound to the anterior segment of the eye, which occurred during another procedure. | 40 | $570 | $20.5K |
| 65855 | In this procedure, the provider uses a laser to burn the trabecular meshwork, the tissue of mesh where the iris meets the sclera, to drain aqueous humor from the anterior chamber and treat glaucoma. | 150 | $100 | $15.6K |
| 67904 | The provider repairs a drooping eyelid by tightening the levator muscle that controls eyelid movement to improve cosmetic appearance or remove the obstruction to a patient’s vision. He accesses the… | 30 | $580 | $15.5K |
Showing 1–10 of 13
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 13 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
13 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 66984 | 39 | 330 | 170 | $200 | $143.2K |
| V2785 | 5 | 10 | 20 | $3,630 | $101.6K |
| 66991 | 12 | 50 | 30 | $1,640 | $70.7K |
| 65820 | 5 | 30 | 30 | $1,050 | $37.9K |
| 66982 | 5 | 140 | 30 | $680 | $36.9K |
| 67904 | 14 | 20 | 40 | $650 | $27.3K |
| 66821 | 6 | 240 | 40 | $210 | $17.4K |
| 66250 | 1 | 10 | 20 | $560 | $13.4K |
| 66170 | 1 | 10 | 20 | $700 | $13.2K |
| 66710 | 6 | 10 | 10 | $570 | $9.1K |
Showing 1–10 of 13
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
3 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 230 | $300 | $66.7K |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 500 | $1 | $500 |
| J2280 | Injection, moxifloxacin, 100 mg | 30 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Massachusetts providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Massachusetts median
3 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 37 | 60 | 330 | $380 | $352.9K |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 15 | 40 | 350 | $1 | $560 |
| J2280 | Injection, moxifloxacin, 100 mg | 1 | 10 | 20 | $0 | $0 |
Other providers in the same ZIP code as Boston Eye Surgery & Laser Center Trust, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Jewish Family & Children's Service | MA | Foster Care Agency | $0 | $11.6M |
| Exosome Diagnostics, Inc. | MA | Clinical Medical Laboratory | $8.9M | $310.6K |
| Children's Dental Of Waltham, P.C. | MA | General Practice Dentistry | $0 | $7.2M |
| West Suburban Eye Surgery Center LLC | MA | Ophthalmologic Surgery Clinic/Center | $4.9M | $1.2M |
| Quantum Pathology, LLC | MA | Anatomic Pathology & Clinical Pathology Physician | $3.1M | $913.7K |
| Peter Chang | MA | Ophthalmology Physician | $1.3M | $0 |
| Boston Out-patient Surgical Suites, LLC | MA | Ambulatory Surgical Clinic/Center | $693.9K | $0 |
| Stephen Anesi | MA | Ophthalmology Physician | $550.8K | $0 |
| Geoffrey Van Flandern | MA | Orthopaedic Surgery Physician | $408.1K | $0 |
| Ambika Hoguet | MA | Ophthalmology Physician | $375.6K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.